MedPath

Vitpro® Neurovi Capsule

Registration Number: MAL21126051NC

Approved
Approval ID

3f9d1f8f1578f5c6

Registration Number

MAL21126051NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types7 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (7)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
150 CapsulesAvailable
Package Size: 150 Capsules
Status: NPRA Approved
180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved
10 CapsulesAvailable
Package Size: 10 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (7)

PYRIDOXINE HYDROCHLORIDEActive
Monograph: 维生素B6
METHYLCOBALAMINActive
Monograph: 甲钴胺
BENFOTIAMINEActive
Monograph: 苯磷硫胺
FOLIC ACIDActive
Monograph: 叶酸
ALPHA LIPOIC ACIDActive
Monograph: 硫辛酸
CHROMIUM POLYNICOTINATEActive
Monograph: chromium polynicotinate
INOSITOLActive
Monograph: 肌醇

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vitpro® Neurovi Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform